AVANT BIO

Today, we celebrate the incredible advancements and opportunities that arise when cutting-edge technology meets biology. Artificial Intelligence is revolutionizing biotechnology, enabling us to accelerate discoveries, enhance precision, and drive innovation like never before. At AVANT BIO we are proud to invest in pioneering biotechnology tools that leverage AI to solve some of the most pressing challenges in healthcare and life sciences. From predictive analytics to personalized medicine, the fusion of AI and biology is unlocking new frontiers and transforming the future of biotech. Join us in appreciating the transformative power of AI in biotechnology and the endless possibilities it brings to our industry! 🚀🔬 #NationalAIApreciationDay #Biotech #AI #Innovation #Healthcare #LifeSciences #FutureOfBiotech

📣 Just released!, our 2024 Market Outlook for #therapeuticenablingtechnologies, #techbio and #healthtech. Download the full report: https://lnkd.in/gcQ5KxZz The report offers a comprehensive look at the state of the industry based on our market analysis, insights only possible through ongoing discussions with global strategics, input from the founders working in the trenches, and meetings held with investors, family offices, and industry KOLs during a full conference schedule year to date. Investors will gain an understanding of influencing factors and key indicators for these critical segments within Life Sciences, and how they are expected to perform through 2024 and beyond. Founders will gain insights to set expectations as they navigate these uncertain times. #growthequity #innovation #bioprocessing #cellandgenetherapies

Just released, our 2024 Market Outlook for #therapeuticenablingtechnologies #techbio and #healthtech. The report offers a comprehensive look at the state of the industry based on our ongoing market analysis, insights only possible through ongoing discussions with global strategics, input from the founders working in the trenches, and meetings held with investors, family offices, and industry KOLs during a full conference schedule year to date. Investors will gain an understanding of influencing factors and key indicators for these critical segments within Life Sciences, and how they are expected to perform through 2024 and beyond. Founders will gain insights to set expectations as they navigate these uncertain times.

This week Daniella Kranjac, Founding GP, attended NIIMBL | The National Institute for Innovation in Manufacturing Biopharmaceuticals National Meeting and participated in an inspiring "Dancing with Venture” fireside chat also joined by Chris Yochim, Director of Business Development: NIIMBL, and John Bagdonas, CEP, FGE, NDEF VP, Business Development: J.P.Morgan. This event was a fantastic opportunity to connect with industry leaders and delve into groundbreaking discussions shaping the future of biomanufacturing. Key highlights from the meeting were: 💡 Innovation in Biomanufacturing: Experts discussed the latest advancements in biomanufacturing technologies and their impact on the industry. 🤝 Collaboration for Growth: Participated in several discussions on the importance of public-private partnerships in accelerating innovation and driving economic growth. At AVANT BIO, we are committed to staying at the forefront of these developments by playing an integral role in the ecosystem and at events like NIIMBL’s National Meeting so we can foster innovation and growth in the life sciences sector. #Biomanufacturing #Innovation #NIIMBL #AVANTBIO #LifeSciences #growthequity

We are thrilled to have participated in the Private Equity Insights Switzerland 2024 conference! This event brought together industry leaders and innovators, providing invaluable insights and networking opportunities. Here are some topics from the event: 🔹 Future of Private Equity: Discussions on emerging trends and investment strategies shaping the industry. 🔹 Sustainable Investing: Insights on integrating ESG factors and driving positive impact through investments. 🔹 Technology and Innovation: Exploring advancements in healthtech and techbio, and their role in transforming the life sciences sector. 🔹 Women in Private Equity: Celebrating the achievements of women leaders and promoting diversity in the industry. Attending this conference reaffirms our commitment to driving innovation and fostering growth in the life sciences and healthtech sectors. Thank you to the organizers and all the incredible participants for making this a highly productive event! #PrivateEquity #HealthTech #LifeSciences #Innovation #AVANTBIO

Our team at AVANT BIO had an incredible experience attending SuperReturn this week! At AVANT BIO, we believe in the power of collaboration and innovation to drive the future of life sciences, healthtech, and techbio. Attending SuperReturn provided us with invaluable insights into the latest industry trends, opportunities to connect with fellow leaders, and the chance to showcase our commitment to supporting groundbreaking ventures. Networking with some of the brightest minds in the investment community reaffirmed our mission to empower and invest in visionary startups shaping healthcare's future. We're excited to leverage these new connections and knowledge to continue making a positive impact. #SuperReturn #LifeSciences #Healthtech #TechBio #Innovation #Investment #AVANTBIO #Grothequity #Emergingmanagers

We are thrilled to share that AVANT BIO's Founding GP, Daniella Kranjac, recently took the stage at Bridge Funding Global's Bridge Conference in San Francisco, CA.   At AVANT BIO, we are proud to be a woman-led emerging firm and share Bridge Funding Global’s commitment to fostering opportunities for high-performing, diverse emerging managers.    Daniella's presentation underscored our mission to drive innovation and inclusivity. Discover more about AVANT BIO's work and opportunities to partner with us in shaping the future of life sciences by visiting our website here: https://lnkd.in/e4XSDq6w   A heartfelt thank you to Bridge Funding Global for championing diversity and inclusion   #AVANTBIO #BridgeTheGap #WomenInBiotech #DiversityInFunding #Innovation #Biotechnology

We’re excited to announce Daniella Kranjac, Founding GP has been named an INNOVATE100 honoree in the inaugural Innovation Celebration hosted by Innovation+ and the New Jersey Business & Industry Association (NJBIA), on May 14 at the New Brunswick PAC.   Daniella has a long history of supporting innovation in the NJ Life Science sector beginning when she co-founded NJ-based Wave Biotech, LLC while completing her senior year at Stevens Institute of Technology.   More information on the event can be found here: https://lnkd.in/eRfJSyh Thanks to James Barrood and NJBIA for supporting the NJ innovation ecosystem! #innovate100 #innovation #leadership #collaboration #innovatenewjersey

There is enormous opportunity in the life sciences, tech bio, and healthtech spaces across all investment stages. The next medical breakthroughs will come from combining incredible new technologies with a greater understanding of biology. AVANT BIO LLC was launched to invest in these opportunities and is looking to connect with founders and teams advancing tomorrow’s life sciences. We have launched a form for founders seeking funding! Give our team advanced visibility on your company here: https://lnkd.in/grkW3-hm #healthtech #techbio #lifesceicnes #drugdiscovery #biomanufacturing #cellandgenetherapies #growthequity #venturecapital

Sebastien Latapie, Principal at AVANT BIO is headed to Boston where he’ll be judging the BioTools Innovator East Coast pitch event. It’s a great opportunity to meet and support 20 of the most promising startups that are advancing the life sciences industry. #incubator #inovation #startup #venturecapital #growthequity